Press releases

A diagnostic test, developed by experts at the University of Nottingham, will speed up the diagnosis of colorectal cancer in patients ensuring they receive treatment more effectively, potentially saving thousands of lives.

New research, led by experts at the University of Nottingham and funded by Cystic Fibrosis Trust, will aim to establish the cause of gut health symptoms in people with cystic fibrosis (CF).

The University of Nottingham’s Professor Sir Jonathan Van-Tam has been recognised for the critical communications role he played during the Covid-19 pandemic with a prestigious award by the Royal Society.

A Nottingham academic has been recognised as a future leader within applied health research by being awarded a coveted National Institute for Health and Care Research (NIHR) Advanced Fellowship.

Experts at the University of Nottingham, in collaboration with experts at Keele University, have found that the risk of heart attacks and strokes temporarily increases in the four months after a gout flare.

Scientists at the University of Nottingham have made a major breakthrough in understanding how malaria parasites divide and transmit the disease, which could be a major step forwards in helping to prevent one of the biggest killer infections in the world.

A team from the Universities of Nottingham, Loughborough and Lincoln has been awarded £2.5 million by the National Institute for Health Research (NIHR) to deliver evaluations of public health initiatives across the UK.

New research, involving experts from the University of Nottingham, shows that children younger within the school year are more likely to be treated for Attention Deficit Hyperactivity Disorder (ADHD), suggesting immaturity may influence diagnosis.

A new study has shown there could be around eight to ten times as many ancient and veteran trees in England than currently recorded, with estimates ranging from 1.7 to 2.1 million, compared to the 115,000 currently on record.

A major clinical trial, led by experts at the University of Nottingham working in partnership with several Universities and NHS hospitals, has found that by interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled.